Cuba has just achieved an achievement in the fight against the new corona virus. In fact, his vaccine candidate Abdala shows an effectiveness of 92.28% against Covid-19. It was the Cuban pharmaceutical company BioCubaFarma who developed it, who posted the news on their Twitter account yesterday, Monday June 21, 2021.
The second vaccine candidate to be developed and developed in Latin America
“Abdala, CIGB’s Cuban vaccine candidate, shows 92.28% effectiveness after three doses,” he said. In addition, the Cuban head of state Miguel Diaz-Canel was satisfied with the Blue Bird Network. “Faced by two pandemics (the Covid and the Blockade), our scientists from the Finlay Institute and the CIGB have overcome all obstacles and given us two very effective vaccines: Soberana 2 and Abdala,” he let us see. Note that, after Soberana 2, Abdala is the second vaccine candidate to be developed and developed in Latin America. Regarding the latter, its efficiency rate was announced on Saturday June 19th.
A “reassuring” result
According to the Finlay Institute for Vaccination, the effectiveness rate of Soberana 2 after injecting three doses is 62%. In an interview with the Cuban press, Institute Director Vicente Verez described this as a “reassuring” result, as the vaccine candidate also takes into account the variants found in the country. In addition, Soberana 2 and Abdala must now receive approval in some time.